2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Chronic: new trials by email Literature Review of Chronic trials Research Report on Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy Bosutinib, Bone Marrow Transplant, Bone Marrow cells - Leukemia, Myelogenous | Phase 2 | Completed | University of Milano Bicocca | 2 | 2015-11-01 | 2020-11-05 |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia LMB-2 - Leukemia, Lymphocytic | Phase 2 | Completed | National Cancer Institute (NCI) | 15 | 2004-02-29 | 2018-01-23 |
Bronchiolitis Obliterans Syndrome (2) · Leukemia (2) · Hematologic Diseases (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Neoplasms (1)
Bronchial Diseases (2) · Bronchiolitis (2) · Bronchiolitis Obliterans (2) · Bronchitis (2) · Graft vs Host Disease (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Neoplasms by Histologic Type (2) · Organizing Pneumonia (2) · Respiratory Tract Diseases (2) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1)
B3(Fv)-PE38KDEL recombinant immunotoxin (1) · Bone Marrow Transplantation (1) · SLC25A33 protein, human (1) · bosutinib (1)
National Cancer Institute (NCI) (1) · University of Milano Bicocca (1)
Italy (1) · United States (1)
Carlo Gambacorti-Passerini, MD (1) · Robert J Kreitman, M.D. (1)